Sofinnova Investments’s Bolt Biotherapeutics BOLT Stock Holding History

Sofinnova Investments’s Portfolio BOLT Stock Details BOLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Hold	137,721	–	–	0.03%	54
2026 Q1	$556K	Hold	137,721	–	–	0.02%	71
2025 Q4	$753K	Hold	137,721	–	–	0.03%	58
2025 Q3	$733K	Hold	137,721	–	–	0.04%	59
2025 Q2	$795K	Sell	137,721 -1	-0%	-$7	0.05%	58
2025 Q1	$1.1M	Hold	137,722	–	–	0.07%	58
2024 Q4	$1.47M	Hold	137,722	–	–	0.11%	51
2024 Q3	$1.78M	Hold	137,722	–	–	0.14%	51
2024 Q2	$2.07M	Hold	137,722	–	–	0.11%	64
2024 Q1	$3.86M	Hold	137,722	–	–	0.21%	51
2023 Q4	$3.08M	Hold	137,722	–	–	0.17%	42
2023 Q3	$2.86M	Hold	137,722	–	–	0.18%	52
2023 Q2	$3.53M	Hold	137,722	–	–	0.23%	40
2023 Q1	$3.83M	Hold	137,722	–	–	0.24%	43
2022 Q4	$3.58M	Hold	137,722	–	–	0.21%	43
2022 Q3	$4.08M	Hold	137,722	–	–	0.24%	49
2022 Q2	$5.62M	Hold	137,722	–	–	0.47%	38
2022 Q1	$7.55M	Hold	137,722	–	–	0.57%	35
2021 Q4	$13.5M	Hold	137,722	–	–	0.79%	33
2021 Q3	$34.8M	Hold	137,722	–	–	2.06%	10
2021 Q2	$42.6M	Hold	137,722	–	–	2.45%	8
2021 Q1	$90.6M	Buy	+137,722	New	+$89.6M	5.45%	3

Other funds holding BOLT

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T3 Companies New York $93.7M AUM

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Sofinnova Investments's BOLT Position: Q2 2026 in Review

Sofinnova Investments held its Bolt Biotherapeutics (BOLT) position steady in Q2 2026 at 137,721 shares worth $530K. The position accounts for 0.03% of the portfolio, ranked #54.

Sofinnova Investments first reported a position in BOLT in Q1 2021 and has held it in 22 quarters since. The position peaked at $90.6M in Q1 2021. 23 funds tracked by Wall St. Rank hold BOLT as of Q2 2026.

Sofinnova Investments held 137,721 shares of Bolt Biotherapeutics worth $530K as of Q2 2026.
Sofinnova Investments left its Bolt Biotherapeutics share count unchanged in Q2 2026.
Bolt Biotherapeutics made up 0.03% of Sofinnova Investments's portfolio in Q2 2026, its #54 holding.
Sofinnova Investments first reported a position in Bolt Biotherapeutics in Q1 2021 and has held it in 22 quarters since.
Sofinnova Investments's Bolt Biotherapeutics position peaked at $90.6M in Q1 2021.
23 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.